Related by context. Frequent words. (Click for all words.) 61 Traficet EN 57 liposomal formulation 55 double blinded placebo 55 IMC A# 55 tanespimycin 55 myeloproliferative disorders 54 ATL# [001] 54 PREZISTA r 53 orally bioavailable 53 GV# [001] 53 elvitegravir 53 vicriviroc 52 NLX P# 52 EVIZON 52 serologic 51 RRMS patients 51 pharmacodynamic 51 diabetic neuropathy 51 MAb 51 genotypic 51 haematological 51 concomitant medications 50 pharmacodynamics 50 efficacy endpoint 50 PRX# 50 DB# [003] 50 dose cohorts 50 pharmacokinetic profiles 50 nucleoside 49 humanized antibody 49 CCR5 antagonists 49 renal insufficiency 49 secondary efficacy endpoints 49 INTELENCE 49 BNC# 49 ascending doses 48 polymerase inhibitors 48 prospectively defined 48 etravirine 48 aetiology 48 ISENTRESS 48 NNRTIs 48 neurologic symptoms 48 xenograft models 47 Maraviroc 47 Secondary endpoints 47 HBsAg 47 pharmacotherapies 47 seliciclib 47 raltegravir 47 clinical endpoints 47 TMC# [001] 47 mg BID 47 clinically relevant 47 maraviroc 46 placebo controlled clinical trials 46 SUTENT 46 TRX# 46 somatic symptoms 46 phenotyping 46 kinase inhibitor 46 evaluable 46 metabolomic 46 NRTI 45 chemotherapeutic drug 45 laboratory abnormalities 45 SAEs 45 PK PD 45 kinase inhibitors 45 efficacy 44 retinoid 44 nonrandomized 44 nucleoside reverse transcriptase inhibitors 44 nonresponders 44 IFN alpha 44 tipranavir 44 prespecified 44 pharmacokinetics 44 quantitative PCR 43 p = .# [002] 43 hypoglycemic events 43 efficacy endpoints 43 NSABP 43 tumor antigen 43 subgroup analyzes 43 DMARD 42 dosing regimens 42 anticholinergics 42 synthetic peptides 42 chemotherapy regimens 42 dose regimens 42 enfuvirtide 42 protease inhibitor 42 subjects 42 virologic 42 NRTIs 41 neurochemistry 41 ERCP 41 symptom severity 41 geologic modeling 41 darunavir